Simris Alg AB (publ) (SIMRIS-B.ST)
SEK 0.07
(-1.75%)
SEK 0.07
(-1.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.35 Million SEK | 6.72% |
| 2022 | 4.08 Million SEK | -33.52% |
| 2021 | 6.13 Million SEK | 183.33% |
| 2020 | 2.16 Million SEK | 24.27% |
| 2019 | 1.74 Million SEK | 128.8% |
| 2018 | 761.81 Thousand SEK | -10.55% |
| 2017 | 851.63 Thousand SEK | 17.27% |
| 2016 | 726.22 Thousand SEK | 156.62% |
| 2015 | 283 Thousand SEK | 414.55% |
| 2014 | 55 Thousand SEK | -97.28% |
| 2013 | 2.02 Million SEK | 213.05% |
| 2012 | 645.44 Thousand SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 519 Thousand SEK | -80.47% |
| 2024 Q2 | 634 Thousand SEK | 22.16% |
| 2023 Q1 | 488 Thousand SEK | 53.46% |
| 2023 Q3 | 532 Thousand SEK | -21.42% |
| 2023 Q2 | 677 Thousand SEK | 38.73% |
| 2023 FY | 4.35 Million SEK | 6.72% |
| 2023 Q4 | 2.65 Million SEK | 399.44% |
| 2022 FY | 4.08 Million SEK | -33.52% |
| 2022 Q2 | 240 Thousand SEK | -92.51% |
| 2022 Q3 | 316 Thousand SEK | 31.67% |
| 2022 Q4 | 318 Thousand SEK | 0.63% |
| 2022 Q1 | 3.2 Million SEK | 7.69% |
| 2021 Q3 | 1.97 Million SEK | 182.78% |
| 2021 Q1 | 492 Thousand SEK | -9.72% |
| 2021 Q2 | 697 Thousand SEK | 41.67% |
| 2021 FY | 6.13 Million SEK | 183.33% |
| 2021 Q4 | 2.97 Million SEK | 51.04% |
| 2020 Q1 | 265 Thousand SEK | 12.29% |
| 2020 FY | 2.16 Million SEK | 24.27% |
| 2020 Q3 | 1.09 Million SEK | 329.3% |
| 2020 Q2 | 256 Thousand SEK | -3.4% |
| 2020 Q4 | 545 Thousand SEK | -50.41% |
| 2019 Q4 | 236 Thousand SEK | 26.88% |
| 2019 Q3 | 186 Thousand SEK | 28.28% |
| 2019 Q2 | 145 Thousand SEK | -87.67% |
| 2019 Q1 | 1.17 Million SEK | 463.18% |
| 2019 FY | 1.74 Million SEK | 128.8% |
| 2018 Q1 | 202 Thousand SEK | -23.95% |
| 2018 Q3 | 201 Thousand SEK | 34.0% |
| 2018 Q4 | 208.81 Thousand SEK | 3.89% |
| 2018 FY | 761.81 Thousand SEK | -10.55% |
| 2018 Q2 | 150 Thousand SEK | -25.74% |
| 2017 FY | 851.63 Thousand SEK | 17.27% |
| 2017 Q4 | 265.63 Thousand SEK | 1.0% |
| 2017 Q3 | 263 Thousand SEK | 42.16% |
| 2017 Q2 | 185 Thousand SEK | 35.04% |
| 2017 Q1 | 137 Thousand SEK | -44.13% |
| 2016 Q1 | 119 Thousand SEK | 17.82% |
| 2016 Q2 | 147 Thousand SEK | 23.53% |
| 2016 Q3 | 215 Thousand SEK | 46.26% |
| 2016 FY | 726.22 Thousand SEK | 156.62% |
| 2016 Q4 | 245.22 Thousand SEK | 14.06% |
| 2015 Q2 | 62 Thousand SEK | 195.24% |
| 2015 Q3 | 98 Thousand SEK | 58.06% |
| 2015 Q4 | 101 Thousand SEK | 3.06% |
| 2015 Q1 | 21 Thousand SEK | 0.0% |
| 2015 FY | 283 Thousand SEK | 414.55% |
| 2014 FY | 55 Thousand SEK | -97.28% |
| 2013 FY | 2.02 Million SEK | 213.05% |
| 2012 FY | 645.44 Thousand SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | 58.1 Million SEK | 92.507% |
| Ziccum AB (publ) | 3.74 Million SEK | -16.2% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | 615.99 Million SEK | 99.293% |
| Sprint Bioscience AB (publ) | 50.48 Million SEK | 91.376% |
| Mendus AB (publ) | 28.48 Million SEK | 84.716% |
| Genovis AB (publ.) | 158.23 Million SEK | 97.248% |
| Intervacc AB (publ) | 8.01 Million SEK | 45.677% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | 4.37 Million SEK | 0.457% |
| Active Biotech AB (publ) | - SEK | -Infinity% |
| Magle Chemoswed Holding AB (publ) | 170.44 Million SEK | 97.445% |
| Bio-Works Technologies AB (publ) | 43.89 Million SEK | 90.081% |
| Aptahem AB (publ) | 2.63 Million SEK | -65.511% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Kancera AB (publ) | 1.03 Million SEK | -320.676% |
| Infant Bacterial Therapeutics AB (publ) | 77 Thousand SEK | -5554.545% |
| Fluicell AB (publ) | 3.33 Million SEK | -30.437% |
| Saniona AB (publ) | 16.84 Million SEK | 74.145% |
| Lipigon Pharmaceuticals AB (publ) | 16.4 Million SEK | 73.463% |
| Biovica International AB (publ) | 7.29 Million SEK | 40.274% |
| Spago Nanomedical AB (publ) | 1.2 Million SEK | -261.929% |
| AcouSort AB (publ) | 10.55 Million SEK | 58.734% |
| Xintela AB (publ) | 78 Thousand SEK | -5482.051% |
| Abliva AB (publ) | 137 Thousand SEK | -3078.102% |
| Egetis Therapeutics AB (publ) | 57.6 Million SEK | 92.441% |
| Karolinska Development AB (publ) | 2.01 Million SEK | -116.187% |
| OncoZenge AB (publ) | 3000.00 SEK | -145033.333% |
| Amniotics AB (publ) | - SEK | -Infinity% |
| 2cureX AB (publ) | 155 Thousand SEK | -2709.032% |
| CombiGene AB (publ) | 5.54 Million SEK | 21.466% |
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| Calliditas Therapeutics AB (publ) | 1.2 Billion SEK | 99.639% |
| Camurus AB (publ) | 1.71 Billion SEK | 99.746% |
| Corline Biomedical AB | 25.03 Million SEK | 82.605% |
| IRLAB Therapeutics AB (publ) | 5.67 Million SEK | 23.318% |
| Isofol Medical AB (publ) | 721 Thousand SEK | -503.883% |
| I-Tech AB | 120.86 Million SEK | 96.398% |
| Hansa Biopharma AB (publ) | 134.09 Million SEK | 96.753% |
| Cyxone AB (publ) | 5.14 Million SEK | 15.423% |
| ExpreS2ion Biotech Holding AB (publ) | 7.05 Million SEK | 38.241% |
| Biosergen AB | - SEK | -Infinity% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| NextCell Pharma AB | 10.66 Million SEK | 59.174% |
| Xspray Pharma AB (publ) | - SEK | -Infinity% |
| Elicera Therapeutics AB (publ) | 11.23 Million SEK | 61.229% |
| Nanologica AB (publ) | 1.44 Million SEK | -201.733% |
| SynAct Pharma AB | - SEK | -Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| Stayble Therapeutics AB (publ) | - SEK | -Infinity% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| Lipum AB (publ) | 53 Thousand SEK | -8115.094% |
| BioInvent International AB (publ) | 71.46 Million SEK | 93.907% |
| Alzinova AB (publ) | 270 Thousand SEK | -1512.593% |
| Oncopeptides AB (publ) | 35.22 Million SEK | 87.638% |
| Pila Pharma AB (publ) | 1.46 Million SEK | -197.604% |
| Guard Therapeutics International AB (publ) | - SEK | -Infinity% |
| Scandinavian ChemoTech AB (publ) | 2.82 Million SEK | -54.288% |
| Diamyd Medical AB (publ) | 130 Thousand SEK | -3249.231% |
| Xbrane Biopharma AB (publ) | 238.72 Million SEK | 98.176% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |
| Diagonal Bio AB (publ) | 23 Thousand SEK | -18830.435% |